6505--Naproxen Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The VA National Acquisition Center intends to issue an unrestrictive Request for Proposal (RFP) 36E79726R0011 for Naproxen Tablets. This procurement will supply the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA aims to award one contract for an uninterrupted source of supply. The solicitation is expected on or about February 10, 2026, with a tentative closing date of February 24, 2026.
Scope of Work
This opportunity seeks a single responsible offeror to provide various strengths and package sizes of Naproxen Tablets. Key requirements include:
- Supplying Naproxen Tablets in specific dosages (250mg, 375mg, 500mg) and bottle sizes (100, 500 count).
- Offerors must provide the exact drug name as it appears on the label and a unique NDC/UPC number.
- Standard package unit is bottles.
- Contracted items will be distributed through the VA's Pharmaceutical Prime Vendor Programs.
Contract Details
- Opportunity Type: Presolicitation (leading to an RFP)
- Solicitation Number: 36E79726R0011
- Contract Type: Commercial item format in accordance with FAR Part 12.
- Period of Performance: One base year plus four pre-priced one-year option periods.
- Set-Aside: Unrestrictive procurement (no set-aside).
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Product Service Code: 6505 (Drugs And Biologicals)
Key Dates & Submission
- Solicitation Issue Date: On or about February 10, 2026.
- Tentative Closing Date: February 24, 2026, 2:30 PM Central Time, Chicago, USA.
- Submission Method: Electronically issued via www.beta.sam.gov. No paper copies or telephone requests will be accepted.
- Action: Interested offerors must continuously monitor www.beta.sam.gov for the solicitation, amendments, and other documents. All responsible sources may submit an offer.
Estimated Annual Usage
The estimated annual usage in bottles is:
- NAPROXEN 250MG TAB (100 count): 4,420
- NAPROXEN 250MG TAB (500 count): 14,256
- NAPROXEN 375MG TAB (100 count): 1,476
- NAPROXEN 375MG TAB (500 count): 8,553
- NAPROXEN 500MG TAB (100 count): 8,994
- NAPROXEN 500MG TAB (500 count): 115,664
Point of Contact
- Michael Olszewski, Contract Specialist
- Email: Michael.Olszewski@va.gov
- Phone: 708-786-4966